NPPA issued the retail price of Cefuroxime Axetil IP eq. to Anhydrous Cefuroxime 500 mg + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg for M/s Theon Pharmaceuticals Ltd. (Manufacturer) & M/s Emcure Lifesciences Pvt. Ltd. (Marketer)

Dec 29, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on December 26, 2025, issued the retail price of Cefuroxime Axetil IP eq. to Anhydrous Cefuroxime 500 mg + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg for M/s Theon Pharmaceuticals Ltd. (Manufacturer) & M/s Emcure Lifesciences Pvt. Ltd. (Marketer).

The following has been stated: -

• Each film-coated tablet contains: Cefuroxime Axetil IP eq. to Anhydrous Cefuroxime 500 mg + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg for M/s Theon Pharmaceuticals Ltd. (Manufacturer) & M/s Emcure Lifesciences Pvt. Ltd. (Marketer) will be Rs. 63.94/-.

 

[Notification No.:19(4940)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT